首页 > 最新文献

Indian Journal of Critical Care Medicine最新文献

英文 中文
Old Wine in a New Bottle: Vasograde Scale and Biomarkers, Composite Model in Subarachnoid Hemorrhage. 新瓶装陈酒:蛛网膜下腔出血的血管级量表和生物标志物,复合模型。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25112
Balkrishna D Nimavat, Kapil G Zirpe

How to cite this article: Nimavat BD, Zirpe KG. Old Wine in a New Bottle: Vasograde Scale and Biomarkers, Composite Model in Subarachnoid Hemorrhage. Indian J Crit Care Med 2025;29(12):979-982.

如何引用本文:Nimavat BD, Zirpe KG。新瓶装陈酒:蛛网膜下腔出血的血管级量表和生物标志物,复合模型。中华检验医学杂志;2015;29(12):979-982。
{"title":"Old Wine in a New Bottle: Vasograde Scale and Biomarkers, Composite Model in Subarachnoid Hemorrhage.","authors":"Balkrishna D Nimavat, Kapil G Zirpe","doi":"10.5005/jp-journals-10071-25112","DOIUrl":"10.5005/jp-journals-10071-25112","url":null,"abstract":"<p><p><b>How to cite this article:</b> Nimavat BD, Zirpe KG. Old Wine in a New Bottle: Vasograde Scale and Biomarkers, Composite Model in Subarachnoid Hemorrhage. Indian J Crit Care Med 2025;29(12):979-982.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"976-982"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Composite Model - "VASS-DCI" - for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: Role of VASOGRADE and Inflammatory Biomarkers. 动脉瘤性蛛网膜下腔出血后迟发性脑缺血的“vas - dci”复合模型:VASOGRADE和炎症生物标志物的作用
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25098
Prachi Sharma, Radhakrishnan Muthuchellappan, Thomas Francis, Prithu Sharma, Shilpa H Mallesha, Soundarya Nagaraja

Background and aims: Existing clinical prediction tools for delayed cerebral ischemia (DCI) in aneurysmal subarachnoid hemorrhage (aSAH) patients do not integrate systemic inflammatory status, which is increasingly recognized as a contributor to DCI. We evaluated whether adding inflammatory indices, Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI), to existing tools improves DCI prediction.

Patients and methods: This retrospective observational study included 624 adult patients with aSAH who underwent clipping or coiling over a 2-year period. Patients were stratified into DCI and non-DCI groups. Multivariable logistic regression identified independent predictors of DCI, which were used to construct a bedside score (VASS-DCI) based on adjusted odds ratios. Receiver operating characteristic (ROC) analysis, DeLong's test, and decision curve analysis (DCA) were used to assess model performance and clinical utility.

Results: A total of 179 patients (28.7%) developed DCI. Increasing age, VASOGRADE (yellow/red), SII ≥ 2,056,309, and SIRI ≥ 5,568 were independent predictors of DCI. A multivariable model developed using these variables significantly outperformed the VASOGRADE score (AUC 0.774 vs 0.637; p < 0.0001). DCA demonstrated a higher net clinical benefit of the full model across a threshold probability range of 10-55% compared to VASOGRADE. A clinical risk score, the VASS-DCI (range 0-6), was developed using these predictors. The score stratified patients into low (0-2), moderate (3-4), and high-risk (5-6) groups, with corresponding DCI incidences of 11.8, 48.8, and 64.3%, respectively.

Conclusion: The VASS-DCI score integrates inflammatory, clinical, and radiological parameters into a practical bedside tool for early prediction of DCI in aSAH patients.

How to cite this article: Sharma P, Muthuchellappan R, Francis T, Sharma P, Mallesha HS, Nagaraja S. A Composite Model - "VASS-DCI" - for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: Role of VASOGRADE and Inflammatory Biomarkers. Indian J Crit Care Med 2025;29(12):988-995.

背景与目的:动脉瘤性蛛网膜下腔出血(aSAH)患者迟发性脑缺血(DCI)的现有临床预测工具没有整合全身性炎症状态,而全身性炎症状态越来越被认为是DCI的一个因素。我们评估了在现有工具中加入炎症指标,系统性免疫炎症指数(SII)和系统性炎症反应指数(SIRI)是否能改善DCI预测。患者和方法:这项回顾性观察性研究包括624名成年aSAH患者,这些患者在2年内接受了夹持或盘绕手术。将患者分为DCI组和非DCI组。多变量logistic回归确定了DCI的独立预测因子,并根据调整后的优势比构建床边评分(vas -DCI)。采用受试者工作特征(ROC)分析、DeLong检验和决策曲线分析(DCA)评估模型的性能和临床应用。结果:179例(28.7%)发生DCI。年龄增加、VASOGRADE(黄/红)、SII≥2,056309、SIRI≥5,568是DCI的独立预测因子。使用这些变量建立的多变量模型显著优于VASOGRADE评分(AUC 0.774 vs 0.637; p < 0.0001)。与VASOGRADE相比,DCA在10-55%的阈值概率范围内显示出更高的全模型净临床获益。临床风险评分,vas - dci(范围0-6),使用这些预测因子。该评分将患者分为低(0-2)、中(3-4)和高危(5-6)组,相应的DCI发生率分别为11.8%、48.8%和64.3%。结论:vas -DCI评分综合了炎症、临床和放射学参数,是早期预测aSAH患者DCI的实用床边工具。本文引用本文:Sharma P, Muthuchellappan R, Francis T, Sharma P, Mallesha HS, Nagaraja S.动脉瘤性蛛网膜下腔出血后迟发性脑缺血的复合模型:血管grade和炎症生物标志物的作用。中华检验医学杂志;2015;29(12):988-995。
{"title":"A Composite Model - \"VASS-DCI\" - for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: Role of VASOGRADE and Inflammatory Biomarkers.","authors":"Prachi Sharma, Radhakrishnan Muthuchellappan, Thomas Francis, Prithu Sharma, Shilpa H Mallesha, Soundarya Nagaraja","doi":"10.5005/jp-journals-10071-25098","DOIUrl":"10.5005/jp-journals-10071-25098","url":null,"abstract":"<p><strong>Background and aims: </strong>Existing clinical prediction tools for delayed cerebral ischemia (DCI) in aneurysmal subarachnoid hemorrhage (aSAH) patients do not integrate systemic inflammatory status, which is increasingly recognized as a contributor to DCI. We evaluated whether adding inflammatory indices, Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI), to existing tools improves DCI prediction.</p><p><strong>Patients and methods: </strong>This retrospective observational study included 624 adult patients with aSAH who underwent clipping or coiling over a 2-year period. Patients were stratified into DCI and non-DCI groups. Multivariable logistic regression identified independent predictors of DCI, which were used to construct a bedside score (VASS-DCI) based on adjusted odds ratios. Receiver operating characteristic (ROC) analysis, DeLong's test, and decision curve analysis (DCA) were used to assess model performance and clinical utility.</p><p><strong>Results: </strong>A total of 179 patients (28.7%) developed DCI. Increasing age, VASOGRADE (yellow/red), SII ≥ 2,056,309, and SIRI ≥ 5,568 were independent predictors of DCI. A multivariable model developed using these variables significantly outperformed the VASOGRADE score (AUC 0.774 vs 0.637; <i>p</i> < 0.0001). DCA demonstrated a higher net clinical benefit of the full model across a threshold probability range of 10-55% compared to VASOGRADE. A clinical risk score, the VASS-DCI (range 0-6), was developed using these predictors. The score stratified patients into low (0-2), moderate (3-4), and high-risk (5-6) groups, with corresponding DCI incidences of 11.8, 48.8, and 64.3%, respectively.</p><p><strong>Conclusion: </strong>The VASS-DCI score integrates inflammatory, clinical, and radiological parameters into a practical bedside tool for early prediction of DCI in aSAH patients.</p><p><strong>How to cite this article: </strong>Sharma P, Muthuchellappan R, Francis T, Sharma P, Mallesha HS, Nagaraja S. A Composite Model - \"VASS-DCI\" - for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: Role of VASOGRADE and Inflammatory Biomarkers. Indian J Crit Care Med 2025;29(12):988-995.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"988-995"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. 作者回应:时机问题:早期抗利尿激素治疗感染性休克的谨慎和机会。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25110
Anirban Bhattacharjee, Priyankar K Datta, Rajathadri H Ravikumar, Prachee Sathe, Vivek Kumar, Riddhi Kundu

How to cite this article: Bhattacharjee A, Datta PK, Ravikumar RH, Sathe P, Kumar V, Kundu R. Author Response: Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. Indian J Crit Care Med 2025;29(12):1059-1060.

Bhattacharjee A, Datta PK, Ravikumar RH, Sathe P, Kumar V, Kundu R.作者回复:时机问题:感染性休克早期抗压激素的谨慎和机会。中华检验医学杂志;2015;29(12):1059-1060。
{"title":"Author Response: Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock.","authors":"Anirban Bhattacharjee, Priyankar K Datta, Rajathadri H Ravikumar, Prachee Sathe, Vivek Kumar, Riddhi Kundu","doi":"10.5005/jp-journals-10071-25110","DOIUrl":"10.5005/jp-journals-10071-25110","url":null,"abstract":"<p><p><b>How to cite this article:</b> Bhattacharjee A, Datta PK, Ravikumar RH, Sathe P, Kumar V, Kundu R. Author Response: Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. Indian J Crit Care Med 2025;29(12):1059-1060.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1059-1060"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Personalized Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill Patients: A Systematic Review and Meta-analysis. 个性化肠外营养对危重患者炎症标志物和临床结果的影响:系统回顾和荟萃分析
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25089
Othman Gatar, Atheer A Arishi, Maryam A Sultan, Mohanned M Gatar

Background and aims: Personalized parenteral nutrition (PPN) is a customized strategy to address the individual metabolic and nutritional requirements of the critically ill patients, especially in cases where enteral nutrition (EN) is not possible. However, available evidence regarding its effectiveness and safety is still inconclusive. This systematic review and meta-analysis aim to evaluate the impact of PPN on the clinical outcome of critically ill patients, including its effect on their length of stay in the intensive care unit (ICU), morbidity, and mortality.

Methodology: A systematic literature search was conducted in PubMed, EMBASE, and Cochrane databases. Information pertinent to the question was retrieved from the selected studies by using a structured data extraction form. Included studies were those that had assessed the impact on clinical outcomes of PPN in critically ill patients. Data were synthesized using a random-effects meta-analysis model. An odds ratio (OR) with 95% confidence intervals (CIs) was used as the pooled effect size.

Results: The meta-analysis included seven studies. The clinical risk was significantly higher in PPN with an OR of 1.24 (95% CI: 1.10-1.39; p < 0.01). Although there were some studies that showed an improvement in nutritional markers and decreased inflammation, the overall impact on mortality and the length of stay in the ICU was inconsistent with considerable clinical and methodological heterogeneity ( = 81%).

Conclusion: Personalized parenteral nutrition has demonstrated improved benefits in tailored nutritional support for critically ill patients. The evidence, however, has shown mixed clinical outcomes, and its effect on mortality and morbidity has been inconclusive. Future research is needed to optimize the composition of PPN formulations and evaluate the long-term effects of this intervention.

How to cite this article: Gatar O, Arishi AA, Sultan MA, Gatar MM. Impact of Personalized Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(12):1040-1049.

背景和目的:个性化肠外营养(PPN)是一种针对危重患者个体代谢和营养需求的定制策略,特别是在无法进行肠内营养(EN)的情况下。然而,关于其有效性和安全性的现有证据仍然没有定论。本系统综述和荟萃分析旨在评估PPN对危重患者临床结局的影响,包括其对重症监护病房(ICU)住院时间、发病率和死亡率的影响。方法:在PubMed, EMBASE和Cochrane数据库中进行系统的文献检索。通过使用结构化数据提取表从选定的研究中检索与问题相关的信息。纳入的研究评估了重症患者PPN对临床结果的影响。数据采用随机效应荟萃分析模型进行综合。采用95%置信区间(ci)的优势比(OR)作为合并效应大小。结果:meta分析包括7项研究。PPN的临床风险显著增高,OR为1.24 (95% CI: 1.10 ~ 1.39; p < 0.01)。虽然有一些研究显示营养指标的改善和炎症的减少,但对死亡率和ICU住院时间的总体影响与相当大的临床和方法学异质性不一致(I²= 81%)。结论:个性化肠外营养在危重患者的量身定制营养支持中显示出改善的益处。然而,证据显示临床结果好坏参半,其对死亡率和发病率的影响尚无定论。未来的研究需要优化PPN配方的组成,并评估这种干预措施的长期效果。Gatar O, Arishi AA, Sultan MA, Gatar MM.个性化肠外营养对重症患者炎症标志物和临床结局的影响:系统回顾和meta分析。中华检验医学杂志;2015;29(12):1040-1049。
{"title":"Impact of Personalized Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill Patients: A Systematic Review and Meta-analysis.","authors":"Othman Gatar, Atheer A Arishi, Maryam A Sultan, Mohanned M Gatar","doi":"10.5005/jp-journals-10071-25089","DOIUrl":"10.5005/jp-journals-10071-25089","url":null,"abstract":"<p><strong>Background and aims: </strong>Personalized parenteral nutrition (PPN) is a customized strategy to address the individual metabolic and nutritional requirements of the critically ill patients, especially in cases where enteral nutrition (EN) is not possible. However, available evidence regarding its effectiveness and safety is still inconclusive. This systematic review and meta-analysis aim to evaluate the impact of PPN on the clinical outcome of critically ill patients, including its effect on their length of stay in the intensive care unit (ICU), morbidity, and mortality.</p><p><strong>Methodology: </strong>A systematic literature search was conducted in PubMed, EMBASE, and Cochrane databases. Information pertinent to the question was retrieved from the selected studies by using a structured data extraction form. Included studies were those that had assessed the impact on clinical outcomes of PPN in critically ill patients. Data were synthesized using a random-effects meta-analysis model. An odds ratio (OR) with 95% confidence intervals (CIs) was used as the pooled effect size.</p><p><strong>Results: </strong>The meta-analysis included seven studies. The clinical risk was significantly higher in PPN with an OR of 1.24 (95% CI: 1.10-1.39; <i>p</i> < 0.01). Although there were some studies that showed an improvement in nutritional markers and decreased inflammation, the overall impact on mortality and the length of stay in the ICU was inconsistent with considerable clinical and methodological heterogeneity (<i>I²</i> = 81%).</p><p><strong>Conclusion: </strong>Personalized parenteral nutrition has demonstrated improved benefits in tailored nutritional support for critically ill patients. The evidence, however, has shown mixed clinical outcomes, and its effect on mortality and morbidity has been inconclusive. Future research is needed to optimize the composition of PPN formulations and evaluate the long-term effects of this intervention.</p><p><strong>How to cite this article: </strong>Gatar O, Arishi AA, Sultan MA, Gatar MM. Impact of Personalized Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(12):1040-1049.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1040-1049"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Sodium, Potassium, Hemoglobin, and Glucose Levels by Blood Gas Analyzer and Hospital Laboratory Autoanalyzer in Emergency Department Settings: A Cross-sectional Study. 急诊科血气分析仪和医院实验室自动分析仪检测钠、钾、血红蛋白和葡萄糖水平的比较:一项横断面研究。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25100
Geeta Mittal, Kanchan Gupta, Aarushi Kaushal, Ritvik Chauhan, Nishant Sharma, Karanjot Singh, Vasul Jain

Background: In emergency department (ED) settings, accurate and timely measurement of biochemical parameters like sodium, potassium, hemoglobin (Hb), and glucose is critical for initiating appropriate interventions. These parameters can be measured by a hospital laboratory autoanalyzer (HLA) or a blood gas analyzer (BGA). Although BGAs, as compared to HLAs, are able to deliver rapid results at the point of care, their accuracy has been a subject of debate. Therefore, this study was designed to compare them and determine their interchangeability.

Patients and methods: A prospective, cross-sectional study was conducted in 1,000 adult patients in the Emergency Medicine Department. Both arterial sampling for blood gas analysis and venous sampling for laboratory analysis were taken simultaneously. The reliability between two measurements was evaluated using the intraclass correlation coefficient (ICC), and agreement was assessed using Bland-Altman analysis with 95% limits of agreement (LOA).

Results: The intraclass correlation coefficient indicated good to excellent reliability for all parameters: Sodium (ICC = 0.946, 95% CI: 0.790-0.976), potassium (ICC = 0.907, 95% CI: 0.769-0.951), Hb (ICC = 0.947, 95% CI: 0.938-0.953), and glucose (ICC = 0.967, 95% CI: 0.962-0.971). The Bland-Altman plot showed moderate to high agreement for sodium, potassium, and Hb levels, and the mean bias was within acceptable limits. Despite the excellent ICC and high correlation for glucose, the Bland-Altman analysis revealed a substantial bias (+6.19 mg/dL) and very wide LOA (-67.69 to +80.07 mg/dL), indicating poor agreement.

Conclusion: We advocate the use of BGA for sodium, potassium, and Hb measurement in emergency settings for quick decision-making. However, glucose measurements from BGA require careful interpretation and should be supplemented with laboratory testing.

How to cite this article: Mittal G, Gupta K, Kaushal A, Chauhan R, Sharma N, Singh K, et al. Comparison of Sodium, Potassium, Hemoglobin, and Glucose Levels by Blood Gas Analyzer and Hospital Laboratory Autoanalyzer in Emergency Department Settings: A Cross-sectional Study. Indian J Crit Care Med 2025;29(12):1020-1025.

背景:在急诊科(ED)设置中,准确及时地测量生化参数,如钠、钾、血红蛋白(Hb)和葡萄糖对于启动适当的干预措施至关重要。这些参数可以通过医院实验室自动分析仪(HLA)或血气分析仪(BGA)测量。尽管与hla相比,BGAs能够在护理点提供快速结果,但其准确性一直存在争议。因此,本研究旨在比较它们并确定它们的互换性。患者和方法:对急诊科1000名成年患者进行了前瞻性横断面研究。同时采集动脉血样用于血气分析,静脉血样用于实验室分析。使用类内相关系数(ICC)评估两个测量值之间的可靠性,使用Bland-Altman分析评估一致性,一致性限为95% (LOA)。结果:类内相关系数对钠(ICC = 0.946, 95% CI: 0.790-0.976)、钾(ICC = 0.907, 95% CI: 0.769-0.951)、Hb (ICC = 0.947, 95% CI: 0.938-0.953)、葡萄糖(ICC = 0.967, 95% CI: 0.962-0.971)等参数均具有良好至极好的信度。Bland-Altman图显示钠、钾和血红蛋白水平有中等到高度的一致性,平均偏差在可接受范围内。尽管有很好的ICC和葡萄糖的高相关性,Bland-Altman分析显示了很大的偏差(+6.19 mg/dL)和非常宽的LOA(-67.69至+80.07 mg/dL),表明一致性不高。结论:我们提倡在紧急情况下使用BGA测量钠、钾和血红蛋白,以便快速决策。然而,BGA的葡萄糖测量值需要仔细解释,并应辅以实验室测试。如何引用本文:Mittal G, Gupta K, Kaushal A, Chauhan R, Sharma N, Singh K等。急诊科血气分析仪和医院实验室自动分析仪检测钠、钾、血红蛋白和葡萄糖水平的比较:一项横断面研究。中华检验医学杂志;2015;29(12):1020-1025。
{"title":"Comparison of Sodium, Potassium, Hemoglobin, and Glucose Levels by Blood Gas Analyzer and Hospital Laboratory Autoanalyzer in Emergency Department Settings: A Cross-sectional Study.","authors":"Geeta Mittal, Kanchan Gupta, Aarushi Kaushal, Ritvik Chauhan, Nishant Sharma, Karanjot Singh, Vasul Jain","doi":"10.5005/jp-journals-10071-25100","DOIUrl":"10.5005/jp-journals-10071-25100","url":null,"abstract":"<p><strong>Background: </strong>In emergency department (ED) settings, accurate and timely measurement of biochemical parameters like sodium, potassium, hemoglobin (Hb), and glucose is critical for initiating appropriate interventions. These parameters can be measured by a hospital laboratory autoanalyzer (HLA) or a blood gas analyzer (BGA). Although BGAs, as compared to HLAs, are able to deliver rapid results at the point of care, their accuracy has been a subject of debate. Therefore, this study was designed to compare them and determine their interchangeability.</p><p><strong>Patients and methods: </strong>A prospective, cross-sectional study was conducted in 1,000 adult patients in the Emergency Medicine Department. Both arterial sampling for blood gas analysis and venous sampling for laboratory analysis were taken simultaneously. The reliability between two measurements was evaluated using the intraclass correlation coefficient (ICC), and agreement was assessed using Bland-Altman analysis with 95% limits of agreement (LOA).</p><p><strong>Results: </strong>The intraclass correlation coefficient indicated good to excellent reliability for all parameters: Sodium (ICC = 0.946, 95% CI: 0.790-0.976), potassium (ICC = 0.907, 95% CI: 0.769-0.951), Hb (ICC = 0.947, 95% CI: 0.938-0.953), and glucose (ICC = 0.967, 95% CI: 0.962-0.971). The Bland-Altman plot showed moderate to high agreement for sodium, potassium, and Hb levels, and the mean bias was within acceptable limits. Despite the excellent ICC and high correlation for glucose, the Bland-Altman analysis revealed a substantial bias (+6.19 mg/dL) and very wide LOA (-67.69 to +80.07 mg/dL), indicating poor agreement.</p><p><strong>Conclusion: </strong>We advocate the use of BGA for sodium, potassium, and Hb measurement in emergency settings for quick decision-making. However, glucose measurements from BGA require careful interpretation and should be supplemented with laboratory testing.</p><p><strong>How to cite this article: </strong>Mittal G, Gupta K, Kaushal A, Chauhan R, Sharma N, Singh K, <i>et al.</i> Comparison of Sodium, Potassium, Hemoglobin, and Glucose Levels by Blood Gas Analyzer and Hospital Laboratory Autoanalyzer in Emergency Department Settings: A Cross-sectional Study. Indian J Crit Care Med 2025;29(12):1020-1025.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1020-1025"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? 阿维他地尔治疗急性呼吸窘迫综合征——希望还是幻想?
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.5005/jp-journals-10071-25095
Gunjan Chanchalani

How to cite this article: Chanchalani G. Aviptadil in Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? Indian J Crit Care Med 2025;29(11):895-896.

如何引用这篇文章:Chanchalani G. Aviptadil in Aviptadil治疗急性呼吸窘迫综合征-希望还是海市蜃楼?中华检验医学杂志;2015;29(11):895-896。
{"title":"Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage?","authors":"Gunjan Chanchalani","doi":"10.5005/jp-journals-10071-25095","DOIUrl":"10.5005/jp-journals-10071-25095","url":null,"abstract":"<p><p><b>How to cite this article:</b> Chanchalani G. Aviptadil in Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? Indian J Crit Care Med 2025;29(11):895-896.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 11","pages":"895-896"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical Power and Driving Pressure in ARDS: Clarifying Overlap Context and Clinical Meaning. 机械动力和驱动压力在ARDS中的作用:澄清重叠背景和临床意义。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.5005/jp-journals-10071-25085
Jay Prakash, Bodhisatwa Choudhuri

How to cite this article: Prakash J, Choudhuri B. Mechanical Power and Driving Pressure in ARDS: Clarifying Overlap Context and Clinical Meaning. Indian J Crit Care Med 2025;29(11):974-975.

Prakash J, Choudhuri B.机械动力和驱动压力在ARDS中的作用:澄清重叠背景和临床意义。中华检验医学杂志;2015;29(11):974-975。
{"title":"Mechanical Power and Driving Pressure in ARDS: Clarifying Overlap Context and Clinical Meaning.","authors":"Jay Prakash, Bodhisatwa Choudhuri","doi":"10.5005/jp-journals-10071-25085","DOIUrl":"10.5005/jp-journals-10071-25085","url":null,"abstract":"<p><p><b>How to cite this article:</b> Prakash J, Choudhuri B. Mechanical Power and Driving Pressure in ARDS: Clarifying Overlap Context and Clinical Meaning. Indian J Crit Care Med 2025;29(11):974-975.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 11","pages":"974-975"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Mechanical Power and Driving Pressure in Acute Respiratory Distress Syndrome: Clarifying Overlap Context and Clinical Meaning. 作者回应:机械动力和驱动压力在急性呼吸窘迫综合征:澄清重叠背景和临床意义。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.5005/jp-journals-10071-25086
Souvik Chaudhuri, Shwethapriya Rao, Vishwas Parampalli

How to cite this article: Chaudhuri S, Rao S, Parampalli V. Author Response: Mechanical Power and Driving Pressure in Acute Respiratory Distress Syndrome: Clarifying Overlap Context and Clinical Meaning. Indian J Crit Care Med 2025;29(11):976-977.

Chaudhuri S, Rao S, Parampalli V.作者回应:机械动力和驱动压力在急性呼吸窘迫综合征中的作用:澄清重叠背景和临床意义。中华检验医学杂志;2015;29(11):976-977。
{"title":"Author Response: Mechanical Power and Driving Pressure in Acute Respiratory Distress Syndrome: Clarifying Overlap Context and Clinical Meaning.","authors":"Souvik Chaudhuri, Shwethapriya Rao, Vishwas Parampalli","doi":"10.5005/jp-journals-10071-25086","DOIUrl":"10.5005/jp-journals-10071-25086","url":null,"abstract":"<p><p><b>How to cite this article:</b> Chaudhuri S, Rao S, Parampalli V. Author Response: Mechanical Power and Driving Pressure in Acute Respiratory Distress Syndrome: Clarifying Overlap Context and Clinical Meaning. Indian J Crit Care Med 2025;29(11):976-977.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 11","pages":"976-977"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Aspartate Aminotransferase-to-platelet Ratio Index is Associated with Sepsis-associated Liver Dysfunction in Adult Patients with Sepsis: A Retrospective Cohort Study. 成人脓毒症患者初始天冬氨酸转氨酶与血小板比值指数与脓毒症相关的肝功能障碍相关:一项回顾性队列研究
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.5005/jp-journals-10071-25079
Beiyuan Zhang, Xiaoyao Li, Zimeng Qin, Danjiang Dong, Wenkui Yu

Aims and background: Sepsis-associated liver dysfunction (SALD) represents a prevalent and critical complication frequently observed in patients with sepsis. The association between the initial aspartate aminotransferase (AST)-to-platelet (PLT) ratio index (APRI) and SALD is unclear in adult patients diagnosed with sepsis.

Patients and methods: We retrospectively analyzed data from the Medical Information Mart for Intensive Care-IV database. Sepsis-associated liver dysfunction was defined as an elevated serum aminotransaminase (>800 IU/L) or total bilirubin (>2 mg/dL) level. Multivariate and smoothing curve analyses were performed to investigate the relationship between the APRI [APRI = (AST (IU/L)/upper limits of normal)/PLT (k/uL)×100] and SALD. Subgroup analysis was additionally conducted to assess the robustness of the finding. Receiver operating characteristic (ROC) curve was performed to evaluate the discriminatory ability of SALD. External validation was performed using our own dataset.

Results: Overall, 6,334 sepsis patients (SALD, n = 985; no-SALD, n = 5,349) were included. Initial APRI was positively associated with SALD occurrence after controlling for potential confounding variables [odds ratio (OR) = 1.17; 95% confidence interval (CI): 1.15-1.20; p < 0.001]. A nonlinear dose-dependent relationship was found between initial APRI and SALD (p < 0.001). Subgroup analysis revealed no significant interaction between initial APRI and each subgroup divided by age, sex, albumin level, and Sequential Organ Failure Assessment score (p > 0.05). The area under the curve (AUC) for APRI was 0.769 (95% CI: 0.752-0.786), and the optimal cutoff was 0.95. External validation also exhibited good consistency (AUC: 0.761; 95% CI: 0.680-0.842).

Conclusion: A high initial APRI was linked to an elevated risk of developing SALD in adult patients with sepsis, as shown by the non-linear dose-dependent relationship.

Clinical significance: Initial APRI is an easy and accessible tool that can be adopted for timely detection of the risk of SALD and prompt initiation of interventions for adult patients with sepsis.

How to cite this article: Zhang B, Li X, Qin Z, Dong D, Yu W. Initial Aspartate Aminotransferase-to-platelet Ratio Index is Associated with Sepsis-associated Liver Dysfunction in Adult Patients with Sepsis: A Retrospective Cohort Study. Indian J Crit Care Med 2025;29(11):916-924.

目的和背景:脓毒症相关性肝功能障碍(SALD)是脓毒症患者常见的严重并发症。在诊断为败血症的成人患者中,初始天冬氨酸转氨酶(AST)与血小板(PLT)比值指数(APRI)与SALD之间的关系尚不清楚。患者和方法:我们回顾性分析重症监护医疗信息市场- iv数据库的数据。脓毒症相关的肝功能障碍被定义为血清转氨酶(>800 IU/L)或总胆红素(>2 mg/dL)水平升高。采用多变量分析和平滑曲线分析探讨APRI [APRI = (AST (IU/L)/正常上限)/PLT (k/uL)×100]与SALD的关系。另外进行亚组分析以评估该发现的稳健性。采用受试者工作特征(ROC)曲线评价SALD的鉴别能力。外部验证使用我们自己的数据集执行。结果:共纳入6334例脓毒症患者(SALD, n = 985; non -SALD, n = 5349)。在控制了潜在的混杂变量后,初始APRI与SALD的发生呈正相关[优势比(OR) = 1.17;95%置信区间(CI): 1.15-1.20;P < 0.001]。初始APRI与SALD呈非线性剂量依赖关系(p < 0.001)。亚组分析显示,初始APRI与按年龄、性别、白蛋白水平和序期器官衰竭评分划分的各亚组间无显著相互作用(p < 0.05)。APRI的曲线下面积(AUC)为0.769 (95% CI: 0.752 ~ 0.786),最佳截止值为0.95。外部验证也表现出良好的一致性(AUC: 0.761; 95% CI: 0.680-0.842)。结论:高初始APRI与成年脓毒症患者发生SALD的风险升高有关,呈非线性剂量依赖关系。临床意义:初始APRI是一种简单易行的工具,可用于及时发现成年脓毒症患者的SALD风险并及时启动干预措施。张斌,李霞,秦志,董东,于伟。成人脓毒症患者初始天冬氨酸转氨酶与血小板比值指数与脓毒症相关性肝功能障碍的回顾性队列研究。中华检验医学杂志;2015;29(11):916-924。
{"title":"Initial Aspartate Aminotransferase-to-platelet Ratio Index is Associated with Sepsis-associated Liver Dysfunction in Adult Patients with Sepsis: A Retrospective Cohort Study.","authors":"Beiyuan Zhang, Xiaoyao Li, Zimeng Qin, Danjiang Dong, Wenkui Yu","doi":"10.5005/jp-journals-10071-25079","DOIUrl":"10.5005/jp-journals-10071-25079","url":null,"abstract":"<p><strong>Aims and background: </strong>Sepsis-associated liver dysfunction (SALD) represents a prevalent and critical complication frequently observed in patients with sepsis. The association between the initial aspartate aminotransferase (AST)-to-platelet (PLT) ratio index (APRI) and SALD is unclear in adult patients diagnosed with sepsis.</p><p><strong>Patients and methods: </strong>We retrospectively analyzed data from the Medical Information Mart for Intensive Care-IV database. Sepsis-associated liver dysfunction was defined as an elevated serum aminotransaminase (>800 IU/L) or total bilirubin (>2 mg/dL) level. Multivariate and smoothing curve analyses were performed to investigate the relationship between the APRI [APRI = (AST (IU/L)/upper limits of normal)/PLT (k/uL)×100] and SALD. Subgroup analysis was additionally conducted to assess the robustness of the finding. Receiver operating characteristic (ROC) curve was performed to evaluate the discriminatory ability of SALD. External validation was performed using our own dataset.</p><p><strong>Results: </strong>Overall, 6,334 sepsis patients (SALD, <i>n</i> = 985; no-SALD, <i>n</i> = 5,349) were included. Initial APRI was positively associated with SALD occurrence after controlling for potential confounding variables [odds ratio (OR) = 1.17; 95% confidence interval (CI): 1.15-1.20; <i>p</i> < 0.001]. A nonlinear dose-dependent relationship was found between initial APRI and SALD (<i>p</i> < 0.001). Subgroup analysis revealed no significant interaction between initial APRI and each subgroup divided by age, sex, albumin level, and Sequential Organ Failure Assessment score (<i>p</i> > 0.05). The area under the curve (AUC) for APRI was 0.769 (95% CI: 0.752-0.786), and the optimal cutoff was 0.95. External validation also exhibited good consistency (AUC: 0.761; 95% CI: 0.680-0.842).</p><p><strong>Conclusion: </strong>A high initial APRI was linked to an elevated risk of developing SALD in adult patients with sepsis, as shown by the non-linear dose-dependent relationship.</p><p><strong>Clinical significance: </strong>Initial APRI is an easy and accessible tool that can be adopted for timely detection of the risk of SALD and prompt initiation of interventions for adult patients with sepsis.</p><p><strong>How to cite this article: </strong>Zhang B, Li X, Qin Z, Dong D, Yu W. Initial Aspartate Aminotransferase-to-platelet Ratio Index is Associated with Sepsis-associated Liver Dysfunction in Adult Patients with Sepsis: A Retrospective Cohort Study. Indian J Crit Care Med 2025;29(11):916-924.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 11","pages":"916-924"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal and Fetal Outcomes in Pregnant Women Admitted to the Intensive Care Unit with A/H1N1pdm or SARS-CoV-2 Infection: A Retrospective Study. A/H1N1pdm或SARS-CoV-2感染入住重症监护病房的孕妇的母胎结局:一项回顾性研究
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.5005/jp-journals-10071-25075
Vineeth V Thomas, Guruckeeran Nakkeeran, Kirthana R Jacob, Binila Chacko, Mahesh Moorthy, Mahasampath Gowri, Richa Tirkey, Krupa George, Sudha Jasmine, Samuel Hansdak, Jonathan Jayakaran, Sujith Chandy, Benjamin Williams, Divya Deodhar, John V Peter

Background and aims: It is unclear if maternal and fetal outcomes of pregnant women admitted to the intensive care unit (ICU) with A/H1N1pdm and SARS-CoV-2 infection are different.

Patients and methods: This retrospective study (2007-2022) included pregnant women admitted to the ICU with real-time reverse transcription polymerase chain reaction-confirmed A/H1N1pdm or SARS-CoV-2 pneumonia; non-viral pneumonia and incomplete records were excluded. The primary outcome was maternal mortality. Secondary outcomes included need for organ support, duration of ventilation, hospital stay, and fetal outcome. Predictors of maternal mortality were explored using multivariate logistic regression.

Results: Fifty-six women (A/H1N1pdm = 42, SARS-CoV-2 = 14) were admitted to the ICU at a median (interquartile) gestational age of 32.3 (27.3-36) weeks. Gestational diabetes (p = 0.02), hypothyroidism (p = 0.04), hypertension (p = 0.09), and infertility treatment (p = 0.09) were more frequent among SARS-CoV-2 infected women. Time from symptom onset to ICU admission was 4 (3-5) days. Although APACHE-II scores were similar in both groups, a higher proportion of patients with A/H1N1pdm had tachycardia (87.8% vs 21.4%, p = 0.001), and their median oxygen saturation at admission was lower (89% vs 94%, p = 0.02). Ventilatory support (non-invasive and/or invasive support) was required in all A/H1N1pdm patients and 78.6% with SARS-CoV-2 (p = 0.013). Ventilation duration was 12 days (4-18) for SARS-CoV-2 and 4 days (2-7) for A/H1N1pdm (p < 0.001). The frequency of cardiac and renal dysfunction was similar in both groups. Maternal mortality was 21.4% in A/H1N1pdm and 28.6% in SARS-CoV-2; fetal loss was 16.7% and 26.3%, respectively. Four neonatal deaths occurred. Delayed hospital presentation independently predicted maternal mortality (OR: 1.8; 95% CI: 1.07-3.06).

Conclusion: Respiratory failure due to A/H1N1pdm and SARS-CoV-2 infections in pregnancy is associated with high maternal mortality and fetal loss. Delayed presentation is independently associated with maternal death.

How to cite this article: Thomas VV, Nakkeeran G, Jacob KR, Chacko B, Moorthy M, Gowri M, et al. Maternal and Fetal Outcomes in Pregnant Women Admitted to the Intensive Care Unit with A/H1N1pdm or SARS-CoV-2 Infection: A Retrospective Study. Indian J Crit Care Med 2025;29(11):907-915.

背景和目的:目前尚不清楚A/ h1n1 - pdm和SARS-CoV-2感染入住重症监护病房(ICU)的孕妇的母胎结局是否不同。患者和方法:本回顾性研究(2007-2022)纳入ICU收治的实时逆转录聚合酶链反应确诊的A/H1N1pdm或SARS-CoV-2肺炎的孕妇;排除非病毒性肺炎和不完整的记录。主要结局是产妇死亡率。次要结局包括器官支持需求、通气时间、住院时间和胎儿结局。使用多变量逻辑回归探讨产妇死亡率的预测因素。结果:56例A/H1N1pdm = 42, SARS-CoV-2 = 14,中位(四分位间)胎龄为32.3(27.3-36)周。妊娠期糖尿病(p = 0.02)、甲状腺功能减退(p = 0.04)、高血压(p = 0.09)和不孕症治疗(p = 0.09)在SARS-CoV-2感染妇女中更为常见。从症状出现到入住ICU时间为4(3-5)天。尽管两组患者的APACHE-II评分相似,但a /H1N1pdm患者出现心动过速的比例较高(87.8% vs 21.4%, p = 0.001),入院时的中位血氧饱和度较低(89% vs 94%, p = 0.02)。所有A/H1N1pdm患者和78.6%的SARS-CoV-2患者都需要呼吸支持(无创和/或有创支持)(p = 0.013)。SARS-CoV-2患者通气时间为12天(4 ~ 18天),A/H1N1pdm患者通气时间为4天(2 ~ 7天)(p < 0.001)。两组患者出现心功能和肾功能不全的频率相似。A/ h1n1 - pdm的孕产妇死亡率为21.4%,SARS-CoV-2的孕产妇死亡率为28.6%;胎儿丢失率分别为16.7%和26.3%。发生4例新生儿死亡。延迟就诊可独立预测产妇死亡率(OR: 1.8; 95% CI: 1.07-3.06)。结论:妊娠期A/H1N1pdm和SARS-CoV-2感染导致的呼吸衰竭与高孕产妇死亡率和胎儿丢失有关。延迟分娩与产妇死亡独立相关。本文摘自:Thomas VV, Nakkeeran G, Jacob KR, Chacko B, Moorthy M, Gowri M,等。A/H1N1pdm或SARS-CoV-2感染入住重症监护病房的孕妇的母胎结局:一项回顾性研究中华检验医学杂志;2015;29(11):907-915。
{"title":"Maternal and Fetal Outcomes in Pregnant Women Admitted to the Intensive Care Unit with A/H1N1pdm or SARS-CoV-2 Infection: A Retrospective Study.","authors":"Vineeth V Thomas, Guruckeeran Nakkeeran, Kirthana R Jacob, Binila Chacko, Mahesh Moorthy, Mahasampath Gowri, Richa Tirkey, Krupa George, Sudha Jasmine, Samuel Hansdak, Jonathan Jayakaran, Sujith Chandy, Benjamin Williams, Divya Deodhar, John V Peter","doi":"10.5005/jp-journals-10071-25075","DOIUrl":"10.5005/jp-journals-10071-25075","url":null,"abstract":"<p><strong>Background and aims: </strong>It is unclear if maternal and fetal outcomes of pregnant women admitted to the intensive care unit (ICU) with A/H1N1pdm and SARS-CoV-2 infection are different.</p><p><strong>Patients and methods: </strong>This retrospective study (2007-2022) included pregnant women admitted to the ICU with real-time reverse transcription polymerase chain reaction-confirmed A/H1N1pdm or SARS-CoV-2 pneumonia; non-viral pneumonia and incomplete records were excluded. The primary outcome was maternal mortality. Secondary outcomes included need for organ support, duration of ventilation, hospital stay, and fetal outcome. Predictors of maternal mortality were explored using multivariate logistic regression.</p><p><strong>Results: </strong>Fifty-six women (A/H1N1pdm = 42, SARS-CoV-2 = 14) were admitted to the ICU at a median (interquartile) gestational age of 32.3 (27.3-36) weeks. Gestational diabetes (<i>p</i> = 0.02), hypothyroidism (<i>p</i> = 0.04), hypertension (<i>p</i> = 0.09), and infertility treatment (<i>p</i> = 0.09) were more frequent among SARS-CoV-2 infected women. Time from symptom onset to ICU admission was 4 (3-5) days. Although APACHE-II scores were similar in both groups, a higher proportion of patients with A/H1N1pdm had tachycardia (87.8% vs 21.4%, <i>p</i> = 0.001), and their median oxygen saturation at admission was lower (89% vs 94%, <i>p</i> = 0.02). Ventilatory support (non-invasive and/or invasive support) was required in all A/H1N1pdm patients and 78.6% with SARS-CoV-2 (<i>p</i> = 0.013). Ventilation duration was 12 days (4-18) for SARS-CoV-2 and 4 days (2-7) for A/H1N1pdm (<i>p</i> < 0.001). The frequency of cardiac and renal dysfunction was similar in both groups. Maternal mortality was 21.4% in A/H1N1pdm and 28.6% in SARS-CoV-2; fetal loss was 16.7% and 26.3%, respectively. Four neonatal deaths occurred. Delayed hospital presentation independently predicted maternal mortality (OR: 1.8; 95% CI: 1.07-3.06).</p><p><strong>Conclusion: </strong>Respiratory failure due to A/H1N1pdm and SARS-CoV-2 infections in pregnancy is associated with high maternal mortality and fetal loss. Delayed presentation is independently associated with maternal death.</p><p><strong>How to cite this article: </strong>Thomas VV, Nakkeeran G, Jacob KR, Chacko B, Moorthy M, Gowri M, <i>et al</i>. Maternal and Fetal Outcomes in Pregnant Women Admitted to the Intensive Care Unit with A/H1N1pdm or SARS-CoV-2 Infection: A Retrospective Study. Indian J Crit Care Med 2025;29(11):907-915.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 11","pages":"907-915"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12683557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1